Eshhar Z, Waks T, Gross G and Schindler DG: Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody - binding domains and the gamma or zeta subunits of the immunoglobulin and T - cell receptors. Proc Natl Acad Sci U S A. 90: 720-724, 1993.
Imai C, Mihara K, Andreansky M, Nicholson IC, Pui CH, Geiger TL and Campana D: Chimeric receptors with 4 - 1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia. 18: 676-684, 2004.
Porter DL, Levine BL, Kalos M, Bagg A and June CH: Chimeric antigen receptor - modified T cells in chronic lymphoid leukemia. N Engl J Med. 365: 725-733, 2011.
Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL and June CH: Chimeric antigen receptor - modified T cells for acute lymphoid leukemia. N Engl J Med. 368: 1509-1518, 2013.